Very disappointing Q1 numbers, just went through the presentation and Consumer division has done OK but scientific there is a collapse in the EBITDA despite 10% rise in sales, has anyone been able to figure out why?
Also when is the con-call scheduled?
I noticed some losses in subsidiary additions maybe due to Goel Scientific addition but is that the only reason?
| Subscribe To Our Free Newsletter |
